Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.775 USD | -3.49% | -7.64% | -5.05% |
02:31pm | Shattuck Labs Says FDA Grants Orphan Drug Designation to Leukemia Drug; Shares Rise | MT |
02:20pm | Shattuck Labs Gets FDA's Orphan Drug Status for Leukemia Treatment | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.98% | 334M | |
+49.23% | 57.87B | |
+41.65% | 40.25B | |
-6.81% | 39.94B | |
-5.96% | 28.54B | |
+13.15% | 26.4B | |
-19.90% | 19.33B | |
+31.67% | 12.4B | |
+0.44% | 12.23B | |
+24.99% | 12.2B |
- Stock Market
- Equities
- STTK Stock
- News Shattuck Labs, Inc.
- Berenberg Bank Adjusts Shattuck Labs Price Target to $4 From $20, Maintains Buy Rating